A randomized, double-blind, placebo-controlled clinical trial of the effectiveness of the novel serotonin type 3 receptor antagonist ramosetron in both male and female Japanese patients with diarrhea-predominant irritable bowel syndromeMATSUEDA, Kei; HARASAWA, Shigeru; HONGO, Michio et al.Scandinavian journal of gastroenterology. 2008, Vol 43, Num 10, pp 1202-1211, issn 0036-5521, 10 p.Article

High Prevalence of Irritable Bowel Syndrome in Medical Outpatients in JapanSHINOZAKI, Masae; FUKUDO, Shin; ARAKAWA, Tetsuo et al.Journal of clinical gastroenterology. 2008, Vol 42, Num 9, pp 1010-1016, issn 0192-0790, 7 p.Article